Annabelle Friera

Title: Annabelle Friera: Innovator in Angiogenesis and Leukocyte Activation

Introduction

Annabelle Friera is a prominent inventor based in South San Francisco, CA. She has made significant contributions to the fields of angiogenesis and leukocyte activation, holding a total of 2 patents. Her work focuses on developing methods and compositions that have the potential to impact cancer treatment and immune disorders.

Latest Patents

Among her latest patents is "Modulators of Angiogenesis and Tumorigenesis." This invention relates to the regulation of angiogenesis and tumorigenesis, providing methods for identifying and utilizing agents that modulate endothelial cell haptotaxis. It also includes the use of expression profiles and compositions for diagnosing and treating angiogenesis and cancer. Another notable patent is "Modulators of Leukocyte Activation, Hck Compositions and Methods of Use." This invention offers compositions and methods for modulating leukocyte activation, including nucleic acids encoding proteins capable of influencing leukocyte function. It also addresses disorders related to leukocyte dysfunction and provides methods for diagnostic and prognostic determination.

Career Highlights

Annabelle Friera is currently associated with Rigel Pharmaceuticals, Incorporated, where she continues to advance her research and innovations. Her work has positioned her as a key figure in the development of therapeutic strategies targeting critical biological processes.

Collaborations

Throughout her career, Annabelle has collaborated with notable professionals in her field, including James Bradley Lorens and Robert E Atchison. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

Annabelle Friera's innovative work in the fields of angiogenesis and leukocyte activation showcases her dedication to advancing medical science. Her patents reflect her commitment to developing effective treatments for complex health issues.